Prof. Parker holds a PhD in Clinical Biochemistry (D.Phil) at Oxford. He was appointed Principal Scientist at Imperial Cancer Research Fund (Cancer Research UK) in 1990 and has held a joint appointment with King’s College London since 2006. His work along with co-founding of companies has lead to further developed interests and expertise in the area of drug discovery pertinent to oncology. He was elected to the European Molecular Biology Organisation in 1997, to the Academy of Medical Sciences in 2000, where he was awarded the Morton Prize in 2004, elected to the Royal Society in 2006 and elected to the European Academy of Cancer Sciences in 2011. Peter is Head of the Division of Cancer Studies at King’s College London and is a Principal Scientist at the London Research Institute of CRUK (The Francis Crick Institute).